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The hereditary pahnoplantar keratodermas are a het-
erogeneous group of diseases unified by thickening of 
the stratulll corneUlll of the palllls and soles with con-
sequent painful fissuring, discolllfort on pressure, and 
resultant disability. One of the histologic patterns un-
derlying palmoplantar hyperkeratosis is that of epi-
derlllolytic hyperkeratosis. Because that histologic 
pattern has been found in its generalized form to be 
due to keratin gene lllutations, we assessed the inheri-
tance of the form localized to the palllls and soles. In 
each of two falllilies studied, the lllutant gene causing 
the disease is linked strongly to the chromosollle 17 
E pidermolytic hyperkeratosis (EHK) is a histologic pat-tern of epidermal abnormalities characterized especially by vacuolar changes of suprabasal keratinocytes accom-panied by thickening of the I iving epidermis and stratum corneum. Clinically it is found classically in a general-
ized form as the autosomal dominant-inherited bullous congenital 
icllthyosiform erthroderma (BCIE). More localized forms also are 
well described, and among these is one localized to the palms and 
soles, one of the variants of palmoplantar keratoderma (PPK). The 
PPKs are a heterogeneous group of diseases of uncertain nosology 
[1]. Only in the extremely rare Richner-Hanhart variety (tyrosine-
mia, Type II) has a molecular abnormality been described: deficient 
hepatic tyrosine aminotransferase [2]. 
During 1992 and 1993, five groups presented evidence that BCIE 
is due, at least in some families, to inheritance of mutant alleles of 
the genes encoding the suprabasally expressed keratins 1 and 10. 
This evidence included linkage analysis localizing the disease gene 
to sites on chromosomes 12q and 17q known to be the sites of genes 
encoding the basic and acidic keratins [3 - 5], the identification of 
point mutations in these genes [6 - 8), and the production in trans-
genic mice carrying mutant keratin genes of changes in the stratum 
spinosum reminiscent of the human EHK phenotype [9,10) . 
Based on the above data, we and others reasoned that the gene 
encoding keratin 9, the type I keratin expressed suprabasally specifi-
cally in epidermis of palms and soles, would be a good candidate for 
the site of the mutation causing EHK localized to these sites [11,12]. 
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cluster of genes encoding type I keratins, and llluta-
tions are present in the conserved helix initiation re-
gion of keratin 9 in affected members of both kindreds. 
These data, as well as those generated recently by 
others, indicate that keratin gene lllutations may un-
derlie not only the generalized phenotype but also this 
more localized phenotype of epiderlllolytic hyperker-
atosis and suggest one mechanism by which skin dis-
eases can achieve their characteristic localization. Key 
.vords: keratin 9/palmoplantar hyperkeratosis/epidermolytic 
hyperkeratosis / mutations. ] Invest Dermatol 103:474 - 477, 
1994 
We report here evidence validating this hypothesis for two families, 
these data being highly consistent with keratin 9 mutations reported 
very recently in eight other kind reds [13,14). 
MATERIALS AND METHODS 
Collection of blood samples, preparation of DNA, Southern analysis, and 
calculations of two-point linkage analysis were as described [15]. Microsatel-
lite repeats were analyzed following polymerase chain reaction (PCR) am-
plification [16 -18]. Sequencing of keratin 9 genomic DNA was performed 
on PCR-amplified DNA using a PCR Template Prep Kit (Pharmacia) and 
Sequenase T7 polymerase (United States Biochemical). The primers used for 
amplifying exon 1 were base pairs (bp) 161-178 with an EcoRI restriction 
site added: 5' TTT TGA A TT CGC CGC TTC AGC TCC TCA G 3' and 
bp 687 - 666, with a Hind III restriction site added,S' TTT TGG ATC CAA 
TAG TGT TAT AA T AAG GGG AG 3' The latter primer also was used for 
sequencing, as was the following primer: base pairs 669-650, with a Hind 
III restriction site added,S' TTT T AA GCT TGG AGT AGT TCT TCT 
GGA TAG 3'. The numbering ofbp and amino acids is according to Lang-
bein et aJ (1 9]. 
RESULTS 
The two families studied-EHK-PPK-Cl [20] and EHK-PPK-Ei 
[21)- have been described previously. In both, segregation of dis-
ease was compatible with a fully penetrant autosomal dominant 
inheritance (Fig 1). C linical abnormalities were limited strictly to 
the palms and soles and consisted of diffuse thickening of the stra-
tum corneum, which frequently peeled off to uncover a glistening 
surface (Fig 2). Histologic abnormalities were typical of EHK 
(Fig 3). 
DNA samples from all available family members were genotyped 
at polymorphic loci on chromosomes 12q and 17q. Inheritance of 
disease in both kind reds was linked to the region of the type I 
keratin gene cluster on chromosome 17q, with no recombinants and 
a combined lod score of 6.92 (Table I). By contrast, analysis of a 
polymorphic locus in the region of the type II keratin gene cluster 
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Figure 1. Pedigrees of kindreds with EHK-PPK. Sqllares, male; circles, 
female; opel! symbols, clinically normal; closed symbols, abnormal palms and 
soles. 
on chromosome 12q provided strong evidence against linkage in 
both families (Table I). 
Because the helix initiation region is the site at which keratin 
gene mutations have been reported most frequently, we searched 
those sequences for keratin 9 mutations. In the CI kindred, we 
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found a C -+ T substitution at bp 550 resulting in the substitution of 
tryptophane for arginine 162. In the Ei kindred, all six tested af-
fected individuals have an A -+ G substitution at bp 545, resulting 
in the substitution of serine for asparagine 160 (Figs 4 and 5). 
Because the mutation in the Cl kindred is identical to that found 
in three other European families [14] we questioned whether our 
family might be related to the three others. To test this, we assayed 
the number of CA repeats in the microsatellite repeat in intron 4 of 
keratin 9 [14]. Using primers and "standa.rd" samples of genomic 
DNA kindly provided by A. Reis, we found the R162W mutation 
in our family to be on an allele with 24 repeats, clearly differing 
from the R162W mutations in the families ofReis et aI, all of which 
were on alleles with 23 repeats. The N160S mutation arose on an 
allele with 21 repeats. 
DISCUSSION 
Our finding of linkage to 17q in these two families is consistent 
with the findings of keratin gene defects in generalized EHK 
(BCIE). A report of linkage of EHK-PPK to chromosome 17q in 
another family has been published (lod score 6.66) [22], and hence 
the combined lod score for the three families is greater than 13. 
Our finding of mutations at N160 and R162 are remarkable in 
that all eight previously reported mutations are at these same two 
codons [13 ,14]. Perhaps mutations at other regions of the keratin 9 
gene might underlie more subtle abnormalities dismissed clinically 
as being within the range of normal phenotype, e.g., a propensity to 
callus formation, but no data relevant to this point have been pub-
lished. 
More generally, EHK-PPK is but one of many instances oflocali-
zation of the disease to one or another region of the skin [23]. 
Sometimes such localization is correlated with gross structural fea-
tures, e.g., hidradenitis suppurativa at the sites of apocrine glands. In 
the autoimmune bullous diseases pemphigus and bullous pemphi-
goid, blisters tend to occur at sites of greater expression of pemphi-
gus and bullous pemphigoid antigen [24,25]. Findings that keratin 9 
mutations cause PPK-EHK suggest that mutations in genes ex-
pressed locally can cause local disease and that modulation of local 
gene expression might be a therapeutic approach of potential value, 
e.g., induction of keratin 9 synthesis at non-palmoplantar skin 
might reverse the BClE phenotype. Such therapeutic intervention 
c 
Figure 2. Clinical appearance of abnorDlal paltns and soles in affected Dlembers of EHK-PPK kindreds studied. Note sharp demarcations of 
abnormal palms and normal wrists in (A) and (B), as well as post-blister desquamation in (A). 
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Figure 3. Histologic appearance of upper portion of skin from af-
fected individual. Note vacuolar changes of epidermis and massive thick-
ening of stratum corneum. 
Table I. Pairwise Lod Scores Between EHK-PPK and 
Chromosome 12q and 17q Loci" 
Lod Score at (J 
0.00 0.01 0.05 0.10 
C l Kindred 
012S17 -00 -4.21 -2.18 -1.37 
017S579 3.31 3.26 3.04 2.76 
Ei Kindred 
012S17 - 00 -1.53 -0.81 -0.49 
017S800 3.61 3.55 3.30 2.97 
II Paternal and maternal segregation arc combined , and autosomal dominant inheri-
tance with full penetrance and no sporadic cases has been assumed. For chromosome 17, 
results using the two most informative single loci are shown. 
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Figure 4. DNA sequences for the E i and CI kindreds. These illustrate 
the N160S and R162W mutations. 
of course will require a good deal more understanding of the control 
of keratin gene expression. 
It is of note that strict localization to palms and soles versus to the 
general body surface is more immutable in EHK than in EBS, in 
which blisters tend to be generalized (Koebner variant) or localized 
to the hands and feet (Weber-Cockayne variant) . However, "over-
lap" cases of EBS are common. In transgenic mice with abnormal 
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Figure S. Analysis of the N160S mutation in members of the Ei 
kindred. Results shown are of G lanes for six patients (P) and for three 
normal (N) children of these patients and illustrate that the presence of Gat 
bp 545 is limited to affected individuals. 
keratin 14 genes, mutations causing subtle changes in the interme-
diate filament network cause blisters localized to the paws; muta-
tions causing more severe abnormalities of the intermediate fila-
ment network cause generalized blisters [26] . Such correlation in 
humans awaits the identification of more mutations, and thus far no 
body-region - specific differences of epidermal basal cel1 keratins 
(unlike the suprabasal keratins) have been described. Hence the 
mechanism underlying the localization of the effects of mutations 
of genes encoding keratin genes of the basal epidermis in EBS (i.e., 
differences in the specific mutation) and of mutations of genes en-
coding keratins of the suprabasal epidermis in EHK (i.e. , differences 
in the gene that is mutated) may differ quite fundamental1y . 
Final1y, although keratin gene mutations as underlying causes of 
hereditary epidermal diseases just now are " the vogue," it is clear 
that not even all instances of PPK are due to mutations of structural 
genes. Thus the one previously identified molecular abnormality 
underlying palmoplantar hyperkeratosis was in tyrosine amino-
transferase, whose deficiency leads to the very rare Richner-Han-
hardt syndrome (tyrosinemia type II) in which there is crippling 
thickening of the stratum corneum of these sites [2]. 
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